company background image
A048

Osstem Implant KOSDAQ:A048260 Stock Report

Last Price

₩115.30k

Market Cap

₩1.6t

7D

-11.3%

1Y

-13.3%

Updated

30 Sep, 2022

Data

Company Financials +
A048260 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance2/6
Financial Health5/6
Dividends0/6

A048260 Stock Overview

Osstem Implant Co., Ltd. manufactures and supplies dental implants worldwide.

Osstem Implant Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Osstem Implant
Historical stock prices
Current Share Price₩115,300.00
52 Week High₩146,500.00
52 Week Low₩90,700.00
Beta1.19
1 Month Change-13.89%
3 Month Change17.06%
1 Year Change-13.31%
3 Year Change188.97%
5 Year Change65.19%
Change since IPO576.25%

Recent News & Updates

Shareholder Returns

A048260KR Medical EquipmentKR Market
7D-11.3%-5.3%-6.1%
1Y-13.3%-28.6%-29.0%

Return vs Industry: A048260 exceeded the KR Medical Equipment industry which returned -28.6% over the past year.

Return vs Market: A048260 exceeded the KR Market which returned -28.7% over the past year.

Price Volatility

Is A048260's price volatile compared to industry and market?
A048260 volatility
A048260 Average Weekly Movement8.2%
Medical Equipment Industry Average Movement6.0%
Market Average Movement5.9%
10% most volatile stocks in KR Market10.6%
10% least volatile stocks in KR Market3.6%

Stable Share Price: A048260 is more volatile than 75% of KR stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: A048260's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
19972,047Tae-Kwan Umhttps://en.osstem.com

Osstem Implant Co., Ltd. manufactures and supplies dental implants worldwide. It provides dental implant systems, dental equipment and supplies, and integrated solutions and cephalometric analysis software products for dental clinics, as well as dental training services. The company was founded in 1997 and is headquartered in Seoul, South Korea.

Osstem Implant Fundamentals Summary

How do Osstem Implant's earnings and revenue compare to its market cap?
A048260 fundamental statistics
Market Cap₩1.57t
Earnings (TTM)₩41.83b
Revenue (TTM)₩951.14b

37.5x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A048260 income statement (TTM)
Revenue₩951.14b
Cost of Revenue₩367.23b
Gross Profit₩583.91b
Other Expenses₩542.07b
Earnings₩41.83b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)3.07k
Gross Margin61.39%
Net Profit Margin4.40%
Debt/Equity Ratio148.9%

How did A048260 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

10%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is A048260 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A048260?

Other financial metrics that can be useful for relative valuation.

A048260 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.8x
Enterprise Value/EBITDA13.3x
PEG Ratio1x

Price to Earnings Ratio vs Peers

How does A048260's PE Ratio compare to its peers?

A048260 PE Ratio vs Peers
The above table shows the PE ratio for A048260 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average13.6x
A214150 CLASSYS
17.9x24.4%₩874.5b
A145720 Dentium
8.5x17.4%₩720.1b
A085370 Lutronic
10.5x17.7%₩407.5b
A099190 i-SENS
17.7x18.3%₩442.8b
A048260 Osstem Implant
37.5x38.2%₩1.6t

Price-To-Earnings vs Peers: A048260 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the peer average (13.6x).


Price to Earnings Ratio vs Industry

How does A048260's PE Ratio compare vs other companies in the KR Medical Equipment Industry?

Price-To-Earnings vs Industry: A048260 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the KR Medical Equipment industry average (10.5x)


Price to Earnings Ratio vs Fair Ratio

What is A048260's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A048260 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio37.5x
Fair PE Ratio35x

Price-To-Earnings vs Fair Ratio: A048260 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the estimated Fair Price-To-Earnings Ratio (35x).


Share Price vs Fair Value

What is the Fair Price of A048260 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A048260 (₩115300) is trading below our estimate of fair value (₩466059.66)

Significantly Below Fair Value: A048260 is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies

Future Growth

How is Osstem Implant forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


38.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: A048260's forecast earnings growth (38.2% per year) is above the savings rate (3.6%).

Earnings vs Market: A048260's earnings (38.2% per year) are forecast to grow faster than the KR market (17.3% per year).

High Growth Earnings: A048260's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A048260's revenue (16.5% per year) is forecast to grow faster than the KR market (9.9% per year).

High Growth Revenue: A048260's revenue (16.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: A048260's Return on Equity is forecast to be high in 3 years time (39.2%)


Discover growth companies

Past Performance

How has Osstem Implant performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


36.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A048260 has high quality earnings.

Growing Profit Margin: A048260's current net profit margins (4.4%) are lower than last year (21.1%).


Past Earnings Growth Analysis

Earnings Trend: A048260's earnings have grown significantly by 36.8% per year over the past 5 years.

Accelerating Growth: A048260's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A048260 had negative earnings growth (-72.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (12.1%).


Return on Equity

High ROE: A048260's Return on Equity (16.4%) is considered low.


Discover strong past performing companies

Financial Health

How is Osstem Implant's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: A048260's short term assets (₩674.3B) do not cover its short term liabilities (₩933.1B).

Long Term Liabilities: A048260's short term assets (₩674.3B) exceed its long term liabilities (₩71.0B).


Debt to Equity History and Analysis

Debt Level: A048260's net debt to equity ratio (36.9%) is considered satisfactory.

Reducing Debt: A048260's debt to equity ratio has reduced from 150% to 148.9% over the past 5 years.

Debt Coverage: A048260's debt is well covered by operating cash flow (44.1%).

Interest Coverage: A048260's interest payments on its debt are well covered by EBIT (12.1x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Osstem Implant current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


0.26%

Current Dividend Yield

Dividend Yield vs Market

Osstem Implant Dividend Yield vs Market
How does Osstem Implant dividend yield compare to the market?
SegmentDividend Yield
Company (Osstem Implant)0.3%
Market Bottom 25% (KR)1.1%
Market Top 25% (KR)3.6%
Industry Average (Medical Equipment)2.0%
Analyst forecast in 3 Years (Osstem Implant)0.3%

Notable Dividend: A048260's dividend (0.26%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.14%).

High Dividend: A048260's dividend (0.26%) is low compared to the top 25% of dividend payers in the KR market (3.54%).


Stability and Growth of Payments

Stable Dividend: A048260 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.

Growing Dividend: A048260 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: A048260 is not paying a notable dividend for the KR market.


Cash Payout to Shareholders

Cash Flow Coverage: A048260 is not paying a notable dividend for the KR market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Tae-Kwan Um (59 yo)

no data

Tenure

Mr. Tae-Kwan Um served as Senior Managing Director of Osstem Implant Co., Ltd. and served as its Managing Director. He serves as Chief Executive Officer at Osstem Implant Co., Ltd.Mr. Um served as Chief o...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A048260?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme9680.007%
Individual Insiders2,966,71321.8%
Institutions3,836,47328.2%
General Public6,806,00250.0%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 49.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.66%
Kyoo-Ok Choi
2,947,603₩339.9b0%no data
7.54%
Lazard Asset Management LLC
1,026,046₩118.3b-13.95%0.08%
5.29%
KB Asset Management Co., Ltd.
719,567₩83.0b0%3.21%
5.29%
National Pension Service
719,529₩83.0b24.35%0.05%
2.3%
FMR LLC
312,936₩36.1b0%no data
1.19%
Truston Asset Management Co., Ltd.
162,547₩18.7b0%17.55%
1.11%
Principal Global Investors, LLC
150,492₩17.4b0%0.01%
1.03%
Dimensional Fund Advisors LP
140,771₩16.2b0.29%no data
0.88%
Victory Capital Management Inc.
119,444₩13.8b-62.14%0.01%
0.63%
Norges Bank Investment Management
85,844₩9.9b0%no data
0.44%
Bellevue Asset Management AG
59,500₩6.9b0%0.05%
0.44%
BNY Mellon Asset Management
59,279₩6.8b-9.68%no data
0.36%
Pacific Asset Management LLP
48,430₩5.6b0%0.57%
0.21%
AllianceBernstein L.P.
28,258₩3.3b-19.52%no data
0.2%
Mackenzie Financial Corporation
26,558₩3.1b0%no data
0.16%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
22,345₩2.6b-51.76%no data
0.15%
American Century Investment Management Inc
20,800₩2.4b0%no data
0.14%
Jackson National Asset Management, LLC
19,420₩2.2b24.81%0.03%
0.1%
Boston Partners Global Investors, Inc.
14,217₩1.6b37.83%no data
0.077%
Charles Schwab Investment Management, Inc.
10,511₩1.2b-1.05%no data
0.076%
Fidelity International Ltd
10,326₩1.2b0%no data
0.073%
Dae-Young Park
10,000₩1.2b0%no data
0.069%
Schroder Investment Management North America Inc.
9,378₩1.1b-81.12%no data
0.069%
American Beacon Advisors, Inc.
9,366₩1.1b0%0.01%
0.068%
Acadian Asset Management LLC
9,305₩1.1b0%no data

Company Information

Osstem Implant Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Osstem Implant Co., Ltd.
  • Ticker: A048260
  • Exchange: KOSDAQ
  • Founded: 1997
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: ₩1.569t
  • Shares outstanding: 13.61m
  • Website: https://en.osstem.com

Number of Employees


Location

  • Osstem Implant Co., Ltd.
  • 3, Magokjungang 12-ro
  • Gangseo-gu
  • Seoul
  • South Korea


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
A048260KOSDAQ (KOSDAQ)YesCommon StockKRKRWFeb 2007

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/30 00:00
End of Day Share Price2022/09/30 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.